Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Google ScholarÂ
Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584–90.
Google ScholarÂ
Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, Brewer NT. Human papillomavirus vaccination and cervical cancer risk. BMJ. 2022;379:e070115.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11:e197–e206.
Google ScholarÂ
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169–82.
Google ScholarÂ
Liontos M, Kyriazoglou A, Dimitriadis I, Dimopoulos M-A, Bamias A. Systemic therapy in cervical cancer: 30 years in review. Crit Rev Oncol Hematol. 2019;137:9–17.
Google ScholarÂ
Ferrall L, Lin KY, Roden RBS, Hung C-F, Wu TC. Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res. 2021;27:4953–73.
Google ScholarÂ
Zhu W, Zhou B-l, Rong L-j, Ye L, Xu H-j, Zhou Y, et al. Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis. J Zhejiang Univ Sci B. 2020;21:122–36.
Google ScholarÂ
He X, Arslan AD, Ho TT, Yuan C, Stampfer MR, Beck WT. Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties. Oncogenesis. 2014;3:e84-e.
Google ScholarÂ
Ferrarese R, Harsh GR, Yadav AK, Bug E, Maticzka D, Reichardt W, et al. Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. J Clin Investig. 2014;124:2861–76.
Google ScholarÂ
Shan H, Hou P, Zhang M, Li L, Pan Y, Chen F, et al. PTBP1 knockdown in renal cell carcinoma inhibits cell migration, invasion and angiogenesis in vitro and metastasis in vivo via the hypoxia inducible factor-1α pathway. Int J Oncol. 2018:52:1613–22.
Singh A, Roy R, Singh K, Sokhal P, Afroj S, Phadnis S, et al. Dengue virus life cycle and host protein interactions: focus on RNA binding proteins and therapeutic advances. Rev Med Virol. 2025;35:e70025.
Calabretta S, Bielli P, Passacantilli I, Pilozzi E, Fendrich V, Capurso G, et al. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Oncogene. 2015;35:2031–9.
Google ScholarÂ
Cui J, Placzek WJ. PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics. Cell Death Differ. 2016;23:1681–90.
Google ScholarÂ
Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2023;25:211–32.
Google ScholarÂ
Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24:597–613.
Google ScholarÂ
Chen L, Wang Y, Lin J, Song Z, Wang Q, Zhao W, et al. Exportin 4 depletion leads to nuclear accumulation of a subset of circular RNAs. Nat Commun. 2022;13:5769.
Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2021;19:188–206.
Google ScholarÂ
Wu Y, Xu M, Feng Z, Wu H, Wu J, Ha X, et al. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis. Cell Mol Life Sci. 2023;80:256.
Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295.
Huang D, Zhu X, Ye S, Zhang J, Liao J, Zhang N, et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature. 2023;625:593–602.
Google ScholarÂ
Chen Z, Xu Z, Wang Q, Wang L, Zhang H, Wang W, et al. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis. Cell Cycle. 2023;22:2211–28.
Google ScholarÂ
Lv H, Jin S, Zou B, Liang Y, Xie J, Wu S. Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance. Cancer Cell Int. 2021;21:532.
Diao X, Guo C, Zheng H, Zhao K, Luo Y, An M, et al. SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer. Signal Transduct Target Ther. 2023;8:426.
Google ScholarÂ
Zhao Z, Yang W, Kong R, Zhang Y, Li L, Song Z, et al. circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-beta signalling pathway-mediated activation of MMPs in pancreatic cancer. Mol Cancer. 2023;22:152.
Google ScholarÂ
Shao Y, Liu Z, Song X, Sun R, Zhou Y, Zhang D, et al. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Clin Transl Med. 2023;13:e1318.
Google ScholarÂ
Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49–57.
Google ScholarÂ
Guo X, Xi L, Liu Y, Lv W, Li T, Ju A, et al. Dysregulation of CircZNF79(5) modulates YBX1 stability and selective autophagy to drive hepatocellular carcinoma progression. Adv Sci. 2026;13:e10310.
Google ScholarÂ
Wang D, Li Y, Chang W, Feng M, Yang Y, Zhu X, et al. CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2. Cell Death Dis. 2024;15:693.
Google ScholarÂ
Masson A, Paccaud J, Orefice M, Colin E, Makitie O, Cormier-Daire V, et al. PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia. J Clin Invest. 2025;135:e182100.
Attig J, Agostini F, Gooding C, Chakrabarti AM, Singh A, Haberman N, et al. Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing. Cell. 2018;174:1067–81 e17.
Google ScholarÂ
Yi J, Du J, Chen X, Nie RC, Hu GS, Wang L, et al. A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer. Proc Natl Acad Sci USA. 2025;122:e2420383122.
Google ScholarÂ
Zhang Y, Tang X, Wang C, Wang M, Li M, Li X, et al. Zinc finger protein 593 promotes breast cancer development by ensuring DNA damage repair and cell-cycle progression. iScience. 2024;27:111513.
Google ScholarÂ
Yao X, Liu H, Wang Z, Lu F, Chen W, Feng Q, et al. Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production. Oncogene. 2023;42:3206–18.
Google ScholarÂ
Jirawatnotai S, Hu Y, Livingston DM, Sicinski P. Proteomic identification of a direct role for cyclin d1 in DNA damage repair. Cancer Res. 2012;72:4289–93.
Google ScholarÂ
Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011;474:230–4.
Google ScholarÂ
